Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Krishnan Rajesh Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Krishnan Rajesh (Chief Technical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Disposed/sold 75,000 options @ $4.3, valued at $322.5k
Disposed/sold 40,000 options @ $5.76, valued at $230.4k
Disposed/sold 12,470 options @ $3.33, valued at $41.5k
Disposed/sold 160,000 options @ $4.59, valued at $734.4k
Disposed/sold 177,050 options @ $1.94, valued at $343.5k
Disposed/sold 28,750 options @ $1.04, valued at $29.9k
Disposed/sold 220,000 options @ $0.96, valued at $211.2k
Granted 75,000 options @ $0
Granted 40,000 options @ $0
Granted 12,470 options @ $0
Granted 160,000 options @ $0
07/05/2023 4 Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Paid exercise price by delivering 10,897 shares @ $0.36, valued at $3.9k
02/23/2023 4 Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 220,000 options @ $0.96, valued at $211.2k
01/05/2023 4 Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Paid exercise price by delivering 6,238 shares @ $1.02, valued at $6.4k
08/01/2022 4 Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 43,125 shares @ $0
Granted 28,750 options @ $1.04, valued at $29.9k
01/24/2022 4 Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 177,050 options @ $1.94, valued at $343.5k
01/05/2022 4 Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 29,867 shares @ $0
05/27/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy